PharmaBoardroom

Lucy Crespo – CEO, Puerto Rico Science, Technology &…

Lucy Crespo, CEO of the Puerto Rico Science, Technology & Research Trust, takes stock of the Trust’s main achievements since outlining its…

Puerto Rico: A Clinical Trials Destination?

Puerto Rico has long been known for its pharma manufacturing prowess, but multinational companies are increasingly looking to conduct clinical trials…

Taiwan Clinical Trials Snapshot

An overview of all clinical trials conducted in Taiwan between 2011 and 2017. Made with Visme Infographic Maker The number…

Thailand’s Growing Reputation as a Clinical Trials Hub

Thailand is becoming an increasingly attractive location for pharma companies to conduct clinical trials, with multinationals such as Novo Nordisk and…

Eric Wahlberg – CEO, Uppsala University Hospital, Sweden

Eric Wahlberg, CEO of Uppsala University Hospital, Sweden´s oldest university hospital, explains his strategic vision of hospital management and how…

José F. Rodríguez Orengo – CEO, FDI Clinical Research,…

José F Rodríguez Orengo is the CEO and Chief Scientific Officer at the Fundación de Investigación (FDI) Clinical Trials, Puerto Rico’s main…

Rosa Gonzalez Galindo – Senior Vice President of Clinical…

Through a merger between INC Research and inVentiv Health in 2018, Syneos Health has become the industry’s only fully integrated biopharmaceutical…

Nathalie Giraud – Director of Integrated Monitoring…

Nathalie Giraud, director of integrated monitoring investigator services & head of France at PPD, breaks down the strengths and weaknesses of the…

Björn Zoëga – CEO, Karolinska University Hospital, Sweden

The Karolinska University Hospital in Stockholm is one of the largest teaching hospitals in Europe and a globally renowned healthcare institution.…

Göran A. Ando – Chairman of the Board, Novo Nordisk…

Dr Göran A. Ando, former chairman of Novo Nordisk and a Swedish life sciences industry veteran, recently moved back to his home country after over 35…

Alzheimer’s Disease R&D Expenditure Snapshot 2019

Alzheimer's drugs represent a high-risk, high-reward proposition for global pharma. As David H. Crean recently wrote for PharmaBoardroom, "Except for…

Ming-Shiang Wu – Director, Taiwan Clinical Trial Consortium

Professor Ming-Shiang Wu, director of the Taiwan Clinical Trial Consortium, elaborates on the activities of the organization and its role to promote…

Tagged with ALS